Skip to main content

Table 4 Goodness-of-fit results from validation analysis

From: “Fibromyalgia and quality of life: mapping the revised fibromyalgia impact questionnaire to the preference-based instruments”

PANEL A

Instruments

N

Method

Mean Utility

Min Utility

Max Utility

MAE

RMSE

AQoL-8D

177

Observed

0.465

0.155

0.945

-

-

OLS

0.465

0.214

0.751

0.099

0.126

Gamma GLM

0.465

0.269

0.837

0.096

0.124

15D

192

Observed

0.688

0.391

1.000

-

-

OLS

0.688

0.484

0.927

0.070

0.087

Gamma GLM

0.688

0.511

0.965

0.069

0.087

EQ-5D-5 L

191

Observed

0.490

−0.480

1.000

-

-

OLS

0.490

−0.076

0.814

0.138

0.174

Gamma GLM

0.489

0.016

0.871

0.137

0.175

SF-6D

141

Observed

0.561

0.345

1.000

-

-

OLS

0.560

0.415

0.739

0.064

0.081

Gamma GLM

0.560

0.431

0.756

0.064

0.081

PANEL B

Instruments

N

Method

Mean Utility

Min Utility

Max Utility

MAE

RMSE

AQoL-8D

177

Observed

0.465

0.155

0.945

-

-

OLS

0.465

0.218

0.808

0.098

0.124

Gamma GLM

0.465

0.271

0.901

0.097

0.124

15D

192

Observed

0.688

0.391

1.000

-

-

OLS

0.689

0.498

0.942

0.072

0.089

Gamma GLM

0.689

0.521

0.985

0.071

0.089

EQ-5D-5 L

191

Observed

0.490

−0.480

1.000

-

-

OLS

0.491

−0.085

0.843

0.138

0.174

Gamma GLM

0.490

0.014

0.891

0.137

0.175

SF-6D

141

Observed

0.561

0.345

1.000

-

-

OLS

0.559

0.411

0.743

0.066

0.084

Gamma GLM

0.559

0.428

0.761

0.067

0.084

  1. Validation analysis dividing the sample into 5 groups (80% as predictor and 20% as predicted)
  2. Panel A: FIQR, Squared-FIQR, Age
  3. Panel B: FIQR function domain; FIQR overall impact domain; FIQR symptom domain; Squared FIQR function domain; Squared FIQR overall impact domain; Squared FIQR symptom domain; Age
  4. Gamma GLM: Generalized linear model Gamma log-link